Hung ML, et al. - In this retrospective cohort study, researchers ascertained if receipt of radioactive iodine (RAI) after reoperation for recurrent papillary thyroid cancer (PTC) is associated with improved outcomes. From April 2006 to January 2016, electronic health record data from 102 patients who underwent neck reoperation for persistent or recurrent PTC at a tertiary referral center were included. Patients received RAI after reoperation and patients who underwent reoperation alone had similar outcomes. No significant clinical benefit was gained in relation to RAI after reoperation in this limited series.